drugset

drugset / Trial / NCT06792136

A Study of ONO-1110 in Patients With Major Depressive Disorder

NCT06792136 ↗

Phase 2 Completed 103 enrolled Ono Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Major Depressive Disorder

Timeline

Start: 2025-01-16
Primary completion: 2026-04-09
Completion: 2026-04-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ONO-1110	Unknown	—	—

Indications